Publication Name	World Journal of Clinical Cases
Manuscript ID	99811
Country	Mexico

Received	2024-07-31 00:28
Peer-Review Started	2024-07-31 00:28
To Make the First Decision
Return for Revision	2024-08-18 19:06
Revised	2024-08-26 19:52
Second Decision	2024-09-09 02:48
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-09-09 10:59
Articles in Press	2024-09-09 10:59
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-09-19 07:23
Publish the Manuscript Online	2024-10-24 09:16

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Immunology
Manuscript Type	Editorial
Article Title	Cytokine release syndrome induced by anti-programmed death-1 treatment in a psoriasis patient: A dark side of immune checkpoint inhibitors
Manuscript Source	Invited Manuscript
All Author List	José Luis Maldonado-García, Ana Fragozo and Lenin Pavón
ORCID	Author(s) ORCID Number José Luis Maldonado-García http://orcid.org/0000-0003-2694-1290 Ana Fragozo http://orcid.org/0000-0001-5985-675x Lenin Pavón http://orcid.org/0000-0002-6067-6868
Funding Agency and Grant Number	Funding Agency Grant Number Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz NC23189.0.
Corresponding Author	Lenin Pavón, PhD, Professor, Laboratorio de Psicoinmunología, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, 101 Calzada México-Xochimilco, Mexico City 11340, Mexico. lkuriaki@inprf.gob.mx
Key Words	Immune checkpoints inhibitors; Programmed death-1; Cancer immunotherapy; Psoriasis; Cytokine release syndrome; Immune-related adverse events
Core Tip	The introduction of cancer immunotherapies, particularly the utilization of monoclonal antibodies that inhibit immune checkpoints, has yielded significant benefits, including enhanced survival rates and a diminished likelihood of adverse effects. However, immune-related adverse events can manifest in certain patients, presenting mild symptoms such as fever, fatigue, headache, rash, arthralgia, and myalgia. In more severe cases, circulatory shock or multiorgan failure can occur, which can be mortal. This editorial examines the possible immunologic mechanisms underlying cytokine release syndrome and the exacerbation of psoriasis in patients receiving anti-programmed death-1 monoclonal antibodies.
Publish Date	2024-10-24 09:16
Citation	<p>Maldonado-García JL, Fragozo A, Pavón L. Cytokine release syndrome induced by anti-programmed death-1 treatment in a psoriasis patient: A dark side of immune checkpoint inhibitors. <i>World J Clin Cases</i> 2024; 12(35): 6782-6790</p>
URL	https://www.wjgnet.com/2307-8960/full/v12/i35/6782.htm
DOI	https://dx.doi.org/10.12998/wjcc.v12.i35.6782

Full Article (PDF)	WJCC-12-6782-with-cover.pdf
Manuscript File	99811_Auto_Edited_030156.docx
Answering Reviewers	99811-answering-reviewers.pdf
Audio Core Tip	99811-audio.mp3
Conflict-of-Interest Disclosure Form	99811-conflict-of-interest-statement.pdf
Copyright License Agreement	99811-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	99811-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	99811-non-native-speakers.pdf
Peer-review Report	99811-peer-reviews.pdf
Scientific Misconduct Check	99811-scientific-misconduct-check.png
Scientific Editor Work List	99811-scientific-editor-work-list.pdf
CrossCheck Report	99811-crosscheck-report.pdf
CrossCheck Report	99811-crosscheck-report.png